MCID: CNG029
MIFTS: 39

Congenital Mesoblastic Nephroma malady

Categories: Rare diseases, Nephrological diseases, Cancer diseases

Aliases & Classifications for Congenital Mesoblastic Nephroma

About this section
Sources:
11Disease Ontology, 13DISEASES, 30ICD10 via Orphanet, 38MeSH, 39MESH via Orphanet, 44NCIt, 47NIH Rare Diseases, 53Orphanet, 67UMLS, 68UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Congenital Mesoblastic Nephroma:

Name: Congenital Mesoblastic Nephroma 11 47 53 13 67
 
Nephroma, Mesoblastic 38

Classifications:

Orphanet: 53 
Rare renal diseases


External Ids:

Disease Ontology11 DOID:4773
MeSH38 D018201
NCIt44 C6569
Orphanet53 ORPHA2665
MESH via Orphanet39 D018201
UMLS via Orphanet68 C1332965
ICD10 via Orphanet30 D41.0

Summaries for Congenital Mesoblastic Nephroma

About this section
MalaCards based summary: Congenital Mesoblastic Nephroma, also known as nephroma, mesoblastic, is related to cellular congenital mesoblastic nephroma and classic congenital mesoblastic nephroma. An important gene associated with Congenital Mesoblastic Nephroma is ETV6 (ETS Variant 6), and among its related pathways are EGFR Transactivation by Gastrin and Cardiac Progenitor Differentiation. Affiliated tissues include kidney, liver and brain, and related mouse phenotypes are neoplasm and liver/biliary system.

Related Diseases for Congenital Mesoblastic Nephroma

About this section

Diseases in the Adult Mesoblastic Nephroma family:

congenital mesoblastic nephroma

Diseases related to Congenital Mesoblastic Nephroma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 82)
idRelated DiseaseScoreTop Affiliating Genes
1cellular congenital mesoblastic nephroma12.3
2classic congenital mesoblastic nephroma12.3
3ceroid lipofuscinosis, neuronal, 910.5ETV6, NTRK3
4brain stem infarction10.5ETV6, NTRK3
5malignant glandular tumor of peripheral nerve sheath10.5ETV6, NTRK3
6pediatric fibrosarcoma10.5NTRK3, WT1
7bronchiolo-alveolar adenocarcinoma10.4ETV6, NTRK3
8mucinous adenocarcinoma10.4ETV6, IGF2
9aortitis10.4IGF2, WT1
10cerebrum cancer10.3SMARCB1, WT1
11psammomatous meningioma10.3NRAS, WT1
12rhinosporidiosis10.3IGF2, WT1
13sting-associated vasculopathy with onset in infancy10.3SMARCB1, WT1
14hemangioma of liver10.3SMARCB1, WT1
15pulmonary plasma cell granuloma10.3SMARCB1, WT1
16polyhydramnios10.3
17esophagus leiomyoma10.2SMARCB1, WT1
18congenital disorder of glycosylation, type iq10.2KIT, WT1
19dysembryoplastic neuroepithelial tumor10.2KIT, WT1
20cutaneous leiomyosarcoma10.2IGF2, KIT
21malignant dermis tumor10.2IGF2, KIT
22vagina leiomyosarcoma10.2IGF2, KIT
23epithelioid leiomyosarcoma10.2KIT, WT1
24t-b+ severe combined immunodeficiency due to cd3delta/cd3epsilon/cd3zeta10.2KIT, WT1
25pancreatic cancer10.2IGF2, SMARCB1
26toxascariasis10.1NRAS, SMARCB1
27central nervous system sarcoma10.1IGF2, SMARCB1
28sublingual gland adenoid cystic carcinoma10.1KIT, NRAS
29renal hypertension10.1
30sarcoma10.1
31nephrocalcinosis10.1
32fibrosarcoma10.1
33hydrops fetalis10.1
34cocaine abuse10.1ETV6, NRAS, NTRK3
35perivascular epithelioid cell tumor10.1IGF2, KIT
36lateral medullary syndrome10.1KIT, NRAS
37hypersplenism10.1KIT, NRAS
38atrial standstill10.1ETV6, NRAS, NTRK3
39breast squamous cell carcinoma10.1KIT, WT1
40polyomavirus allograft nephropathy10.1KIT, NTRK3
41vulvar sarcoma10.1KIT, NRAS
42parotid gland adenoid cystic carcinoma10.1KIT, NRAS
43malignant fibrous histiocytoma of bone10.1KIT, SMARCB1
44vulvar sebaceous carcinoma10.0KIT, WT1
45biphasic synovial sarcoma10.0KIT, SMARCB1
46thyroid cancer, nonmedullary, 410.0SMARCB1, WT1
47nephrolithiasis/osteoporosis, hypophosphatemic, 110.0CTCF, IGF2, WT1
48critical congenital heart disease10.0KIT, NRAS
49foramen magnum meningioma10.0NTRK3, SMARCB1
50facial nerve disease10.0KIT, NRAS

Graphical network of the top 20 diseases related to Congenital Mesoblastic Nephroma:



Diseases related to congenital mesoblastic nephroma

Symptoms for Congenital Mesoblastic Nephroma

About this section

Drugs & Therapeutics for Congenital Mesoblastic Nephroma

About this section

Drugs for Congenital Mesoblastic Nephroma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 26)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Fentanylapproved, illicit, investigational, vet_approvedPhase 3773437-38-73345
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-Phenethyl-4-N-propionylanilinopiperidine
1-phenethyl-4-N-propionylanilinopiperidine
437-38-7
5-22-08-00049 (Beilstein Handbook Reference)
80832-90-2
990-73-8 (citrate)
AC1L1FQ2
Actiq
BIDD:GT0555
BRN 0494484
CHEBI:119915
CHEMBL596
CID3345
D00320
DB00813
Duragesic
Duragesic (TN)
Duragesic-100
Duragesic-12
Duragesic-25
Duragesic-50
Duragesic-75
Durogesic
EINECS 207-113-6
Fentanest
Fentanil
Fentanil [DCIT]
Fentanila
Fentanila [INN-Spanish]
Fentanilo
Fentanyl
Fentanyl (JAN/USAN/INN)
Fentanyl CII
Fentanyl [INN:BAN]
Fentanyl citrate
Fentanyl-100
Fentanyl-12
Fentanyl-25
 
Fentanyl-50
Fentanyl-75
Fentanylum
Fentanylum [INN-Latin]
HSDB 3329
IONSYS
JNS020QD
L001275
LS-124439
Matrifen
MolPort-003-847-369
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-phenethyl-4-piperidyl)propionanilide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide
N-Phenethyl-4-(N-propionylanilino)piperidine
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenethyl-4-(N-propionylanilino)piperidine
N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
NCGC00168252-01
Nasalfent
Oprea1_152073
Oprea1_207148
PDSP1_000860
PDSP2_000846
Pentanyl
Phentanyl
Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI)
R 4263
Rapinyl
Sentonil
Sublimase
Sublimaze
UNII-UF599785JZ
fentanyl
2Liver ExtractsPhase 3, Phase 1, Phase 23868
3NarcoticsPhase 33486
4pancreatic polypeptidePhase 320
5Adjuvants, AnesthesiaPhase 31588
6Central Nervous System DepressantsPhase 312806
7Peripheral Nervous System AgentsPhase 322776
8AnalgesicsPhase 311287
9AnestheticsPhase 39001
10Analgesics, OpioidPhase 33091
11Anesthetics, GeneralPhase 32787
12Anesthetics, IntravenousPhase 32406
13ColaNutraceuticalPhase 31881
14
EtoposideapprovedPhase 1, Phase 2123233419-42-036462
Synonyms:
(-)-Etoposide
121471-01-0
136598-18-0
201594-04-9
33419-42-0
35317-32-9
4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside
4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)
4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside)
4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside
4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin
4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside
4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside
51854-34-3
76576-58-4
9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one
AB00438905
AC1L1FN8
AC1L1VT3
AC1L6246
AC1NR4OG
AC1O4WGG
AC1O7M1N
AC1Q47JJ
Ambap33419-42-0
BPBio1_000673
BRD-K37798499-001-02-5
BSPBio_000611
Bio1_000489
Bio1_000978
Bio1_001467
C01576
CCRIS 2392
CHEBI:4911
CHEBI:588795
CHEMBL44657
CID11758093
CID284997
CID3310
CID36462
CID5284558
CID6419930
CID6610299
CPD000112002
D00125
DB00773
DEMETHY-EPIPODOPHYLLOTOXIN,ETHYLIDENE GLUCOSIDE,
Demethyl Epipodophyllotoxin Ethylidine Glucoside
Demethyl-epiodophyllotoxin ethylidene glucoside
Demethylepipodophyllotoxin-beta-D-ethylideneglucoside
E0675
E1383_SIGMA
EINECS 251-509-1
EPE
EPEG
ETOP
Epipodophyllotoxin
Epipodophyllotoxin VP-16213
Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside
Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside
Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI)
Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside)
Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside)
Eposide
Eposin
 
Eposin, Vepesid, VP-16, Toposar, Etoposide
Etopol
Etopophos
Etopophos (phosphate salt)
Etoposid
Etoposide
Etoposide (JP15/USP/INN)
Etoposide (VP16)
Etoposide [USAN:INN:BAN:JAN]
Etoposido
Etoposido [INN-Spanish]
Etoposidum
Etoposidum [INN-Latin]
Etosid
HMS1569O13
HMS2052N05
HMS2089F14
HSDB 6517
I06-0248
KBioSS_002410
LS-1214
Lastet
MLS000049957
MLS001074951
MLS001424283
MLS002153463
MLS002207239
MLS002222184
MolPort-003-983-431
MolPort-004-905-001
MolPort-004-955-161
NCGC00025056-02
NChemBio.2007.10-comp19
NK 171
NSC 141540
NSC-141540
NSC141540
Prestwick0_000396
Prestwick1_000396
Prestwick2_000396
Prestwick3_000396
Prestwick_211
S1225_Selleck
SAM001246880
SMR000112002
SPBio_002532
ST056353
Toposar
UNII-6PLQ3CP4P3
VP 16
VP 16 (pharmaceutical)
VP 16-213
VP 16213
VP-16
VP-16-213
VePESID (TN)
VePesid
Vepesid
Vepesid J
Vepeside
ZINC03830818
ZINC03938684
Zuyeyidal
etoposide
nchembio.573-comp8
nchembio873-comp2
trans-Etoposide
15
MechlorethamineapprovedPhase 1, Phase 237751-75-24033
Synonyms:
.Beta.,.beta.'-Dichlorodiethyl-N-methylamine
1, 5-Dichloro-3-methyl-3-azapentane hydrochloride
126-85-2 (N-oxide)
2,2'-Dichloro-N-me
2,2'-Dichloro-N-methyldiethylamine
2,2'-Dichlorodiethyl-methylamine
2,2'-dichloro-N-methyldiethylamine
2-Chloro-N-(2-chloroethyl)-N-methylethanamine
302-70-5 (N-oxide, hydrochloride)
51-75-2
55-86-7 (HYDROCHLORIDE)
AC1L1H9H
Antimit
BRN 0605323
BSPBio_001947
Bis(2-chloroethyl)methylamine
Bis(beta-chloroethyl) methylamine
Bis(beta-chloroethyl)methylamine
C07115
C5H11Cl2N
CCRIS 447
CHEBI:28925
CHEMBL427
CID4033
Carolysine
Caryolysin
Caryolysine
Chloramine (the nitrogen mustard)
Chlorethazine
Chlormethine
Chlormethine (INN)
Chlormethine [INN:BAN]
Chlormethinum [INN-Latin]
Cloramin
Clormetina
Clormetina [INN-Spanish]
D07671
DB00888
Di(2-chloroethyl)methylamine
Dichlor amine
Dichloren
DivK1c_000759
EINECS 200-120-5
ENT-25294
Embechine
Embichin
HMS1920J15
HMS2091B04
HMS502F21
HN-2
HN2
HSDB 5083
I14-8708
IBS-L0033631
IDI1_000759
KBio1_000759
KBio2_001369
KBio2_003937
KBio2_006505
KBio3_001447
 
KBioGR_001448
KBioSS_001369
LS-7559
MBA
Me chloroethamine
Mebichloramine
Mechlorethamine
Mechlorethanamine
Mechloroethamine
Mecloretamina
Mecloretamina [Italian]
Methylbis(2-chloroethyl)amine
Methylbis(beta-chloroethyl)amine
Methyldi(2-chloroethyl)amine
Mitoxine (*Hydrochloride*)
MolPort-001-785-592
Mustargen
Mustine
Mustine note
Mutagen
N,N-Bis(2-chloroethyl)-N-methylamine
N,N-Bis(2-chloroethyl)methylamine
N,N-Di(chloroethyl)methylamine
N-Lost
N-Methyl lost
N-Methyl-2,2'-dichlorodiethylamine
N-Methyl-bis(2-chloroethyl)amine
N-Methyl-bis(beta-chloroethyl)amine
N-Methyl-bis-chloraethylamin
N-Methyl-bis-chloraethylamin [German]
N-Methyl-lost
N-Methyl-lost [German]
N-methyl-bis(2-chloroethyl)amine
NCGC00091835-02
NCGC00091835-03
NCGC00091835-04
NCGC00091835-05
NCI60_041682
NINDS_000759
NSC762
Nitol (*Hydrochloride*)
Nitrogen mustard
Nitrogen mustard (HN-2)
Nitrogranulogen
SPBio_000496
SPECTRUM1500375
Spectrum2_000448
Spectrum3_000484
Spectrum4_000924
Spectrum5_001702
Spectrum_000889
Stickstofflost (*Hydrochloride*)
Stickstofflost (ebewe)
T 1024
T-1024
TL 146
UNII-50D9XSG0VR
beta,Beta'-dichlorodiethyl-N-methylamine
beta,beta'-Dichlorodiethyl-N-methylamine
mechlorethamine
thyldiethylamine
╬▓,╬▓'-dichlorodiethyl-N-methylamine
16
Dasatinibapproved, investigationalPhase 1, Phase 2281302962-49-83062316
Synonyms:
(18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide
1N1
2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide
302962-49-8
AC1MI3ET
AC1Q2P0C
AmbotzLS-1203
Anhydrous dasatinib
BCB03_000715
BMS 354825
BMS dasatinib
BMS-354825
BMS-354825, Sprycel, BMS354825, Dasatinib
BMS354825
C488369
CHEBI:49375
CHEMBL1421
CID3062316
D03658
DB01254
Dasatinib
Dasatinib (USAN)
Dasatinib (anh.)
Dasatinib [USAN]
Dasatinib anhydrous
Dasatinib, BMS 354825
Dasatinibum
EC-000.2122
 
EN002710
FT-0084503
I14-1972
Kinome_3650
LS-186641
LS-187028
LS-187773
MolPort-003-846-143
N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE
N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide
N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, monohydrate
N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide
N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide
N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide
NCGC00181129-01
NSC-732517
NSC732517
S1021_Selleck
SPRYCEL (TN)
Sprycel
Spyrcel
UNII-X78UG0A0RN
anh. dasatinib
dasatinib
dasatinib (anhydrous)
dasatinibum
nchembio.117-comp11
nchembio.162-comp4
nchembio.332-comp1
17
IfosfamideapprovedPhase 1, Phase 23913778-73-23690
Synonyms:
(+-)-Ifosfamid
(+-)-Ifosphamide
(+-)-Tetrahydro-N,3-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
(D,L)-Ifosfamide
(R,S)-Ifosphamide
(R,S)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd
2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis( 2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide (8CI)
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
3,} 2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2- oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
36341-88-5
3778-73-2
84711-20-6
A 4942
AB00513932
AC-2113
AC1L1GHW
ASTA Z 4942
Ambap3778-73-2
Asta Z 4942
BPBio1_000865
BRN 0611835
BSPBio_000785
C07047
CAS-3778-73-2
CCRIS 352
CHEBI:5864
CHEMBL1024
CID3690
Cyfos
D00343
D007069
DB01181
EINECS 223-237-3
HMS1570H07
HMS2090M12
HMS2093N07
HSDB 7023
Holoxan
Holoxan 1000
I-Phosphamide
I06-0494
IFEX (TN)
Ifex
Ifosfamid
Ifosfamida
Ifosfamida [INN-Spanish]
Ifosfamide (JAN/USP/INN)
 
Ifosfamide Sterile
Ifosfamide [USAN:INN:BAN:JAN]
Ifosfamidum
Ifosfamidum [INN-Latin]
Ifosphamide
Ifsofamide
Iphosphamid
Iphosphamid(e)
Iphosphamide
Iso Endoxan
Iso-Endoxan
Isoendoxan
Isofosfamide
Isophosphamide
Isosfamide
LS-102
LS-99799
MJF 9325
MJF-9325
MLS002154021
Mitoxana
Mitoxana, Ifex, Ifosfamide
MolPort-003-666-704
N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German]
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylen ephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide
N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine
NCGC00016639-01
NCGC00179435-01
NCI-C01638
NCI60_000233
NPFAPI-04
NSC 109,724
NSC 109724
NSC-109,724
NSC-109724
NSC109,724
NSC109724
Naxamide
Prestwick0_000833
Prestwick1_000833
Prestwick2_000833
Prestwick3_000833
S1302_Selleck
SMR001233348
SPBio_002706
STL058690
UNII-UM20QQM95Y
WLN: T6NPOTJ AM2G BO B2G
Z 4942
Z-4942
Z4942
ifosfamide
isosfamide
{3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,
18
CarboplatinapprovedPhase 1, Phase 2198041575-94-410339178, 498142, 38904
Synonyms:
(SP-4-2)-diammine[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O']platinum
/h1-3H2,(H,7,8)(H,9,10)
/q
1,1-Cyclobutanedicarboxylate diammine platinum (II)
1,1-Cyclobutanedicarboxylate diammine platinum(II)
2*-1
2*1H2
41575-94-4
70903-55-8
AC-1457
AC1L8I6U
Ambap41575-94-4
BSPBio_003145
C 2538
C2043
C2538_SIGMA
C6H10N2O4Pt
CBDCA
CCRIS 3404
CHEBI:31355
CHEMBL1351
CHEMBL288376
CID10339178
CID2567
CID38904
CID426756
CID498142
CID5352133
CID6398587
CID6603770
Carbopaltin
Carboplatin
Carboplatin (JAN/USP/INN)
Carboplatin (USAN)
Carboplatin [USAN:INN:BAN:JAN]
Carboplatine
Carboplatine [French]
Carboplatino
Carboplatino [Spanish]
Carboplatinum
Carboplatinum [Latin]
Cbdca
Cyclobutane-1,1-dicarboxylate
D01363
DB00958
Diammine(1,1-cyclobutanedicarboxylato)platinum (II)
Diammine(cyclobutane-1,1-dicarboxylato(2-)-O,O')platinum
Diammine-1,1-cyclobutane dicarboxylate platinum II
DivK1c_000892
EINECS 255-446-0
EU-0100230
Ercar
HMS1921J16
HMS2090M05
HMS2092B22
HMS502M14
HSDB 6957
I14-2390
IDI1_000892
IUPAC: Azane
InChI=1/C6H8O4.2H2N.Pt/c7-4(8)6(5(9)10)2-1-3-6
 
JM 8
JM-8
KBio1_000892
KBio2_002009
KBio2_004577
KBio2_007145
KBio3_002645
KBioGR_000713
KBioSS_002009
LS-117689
Lopac-C-2538
Lopac0_000230
MolPort-003-665-501
MolPort-003-845-609
NCGC00015223-01
NCGC00093695-01
NCGC00094961-01
NCGC00094961-02
NCGC00094961-03
NCGC00162099-01
NCGC00162099-02
NCGC00167800-01
NCGC00178242-01
NINDS_000892
NSC 201345
NSC 241240
NSC-241240
NSC201345
NSC241240
Paraplatin
Paraplatin (TN)
Paraplatin, Carboplatin
Paraplatin-AQ
Platinum(+2) Cation
Platinum(II), (1, 1-cyclobutanedicar
Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)
Platinum, {diammine[1,1-cyclobut
S1215_Selleck
SPBio_000716
SPECTRUM1502106
Spectrum2_000898
Spectrum3_001503
Spectrum4_000337
Spectrum5_001094
Spectrum_001529
UNII-BG3F62OND5
azanide
carboplatin
cis -Diammine[1,1-cyclobutane-dicarboxylato] platinum
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II)
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(ii)
cis-Diamine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diamine[1,1-cyclobutanedicarboxylato]platinum(II)
cis-Diammine(1,1-cyclobutanedicarboxylato) platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diammine(cyclobutanedicarboxylato)platinum II
cyclobutane-1,1-dicarboxylic acid
diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum
nchembio.573-comp10
nchembio773-comp2
nchembio873-comp3
platinum(2+)
19Protein Kinase InhibitorsPhase 1, Phase 23612
20Topoisomerase InhibitorsPhase 1, Phase 24945
21Alkylating AgentsPhase 1, Phase 24694
22Isophosphamide mustardPhase 1, Phase 2391
23Etoposide phosphatePhase 1, Phase 21232
24Antineoplastic Agents, AlkylatingPhase 1, Phase 24474
25Antineoplastic Agents, PhytogenicPhase 1, Phase 25420
26tyrosineNutraceuticalPhase 1659

Interventional clinical trials:

idNameStatusNCT IDPhase
1Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainCompletedNCT00538850Phase 3
2Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsActive, not recruitingNCT00788125Phase 1, Phase 2
3Oral TRK Inhibitor LOXO-101 for Treatment of Advanced Pediatric Solid or Primary Central Nervous System TumorsRecruitingNCT02637687Phase 1
4Study of RXDX-101 in Children With Recurrent or Refractory Solid Tumors and Primary CNS Tumors, With or Without TRK, ROS1, or ALK FusionsRecruitingNCT02650401Phase 1
5Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United KingdomUnknown statusNCT00757614
6Study of Kidney Tumors in Younger PatientsRecruitingNCT00898365
7Studying Biomarkers in Samples From Younger Patients With Kidney CancerWithdrawnNCT01642095

Search NIH Clinical Center for Congenital Mesoblastic Nephroma


Cochrane evidence based reviews: nephroma, mesoblastic

Genetic Tests for Congenital Mesoblastic Nephroma

About this section

Anatomical Context for Congenital Mesoblastic Nephroma

About this section

MalaCards organs/tissues related to Congenital Mesoblastic Nephroma:

35
Kidney, Liver, Brain

Animal Models for Congenital Mesoblastic Nephroma or affiliated genes

About this section

MGI Mouse Phenotypes related to Congenital Mesoblastic Nephroma:

40 (show all 14)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020068.5ETV6, KIT, NRAS, SMARCB1, WT1
2MP:00053708.5IGF2, KIT, NRAS, SMARCB1, WT1
3MP:00053918.4IGF2, KIT, NRAS, NTRK3, SMARCB1
4MP:00053818.3ETV6, IGF2, KIT, NRAS, SMARCB1
5MP:00030128.3ETV6, IGF2, KIT, NRAS, NTRK3, WT1
6MP:00053798.2CTCF, ETV6, IGF2, KIT, NRAS, WT1
7MP:00053807.7CTCF, ETV6, IGF2, KIT, NRAS, SMARCB1
8MP:00053847.6CTCF, ETV6, IGF2, KIT, NRAS, SMARCB1
9MP:00053877.6CTCF, ETV6, IGF2, KIT, NRAS, SMARCB1
10MP:00053787.6ETV6, IGF2, KIT, NRAS, NTRK3, SMARCB1
11MP:00053977.6CTCF, ETV6, IGF2, KIT, NRAS, SMARCB1
12MP:00053857.6ETV6, IGF2, KIT, NRAS, NTRK3, SMARCB1
13MP:00107687.2CTCF, ETV6, IGF2, KIT, NRAS, NTRK3

Publications for Congenital Mesoblastic Nephroma

About this section

Articles related to Congenital Mesoblastic Nephroma:

(show top 50)    (show all 143)
idTitleAuthorsYear
1
Congenital mesoblastic nephroma: a study of 19 cases using immunohistochemistry and ETV6-NTRK3 fusion gene rearrangement. (27020209)
2016
2
The Value of Mitotic Count and Ki67 Proliferation Index in Congenital Mesoblastic Nephroma. (27484189)
2016
3
Congenital mesoblastic nephroma: Its diverse clinical features - A literature review with a case report. (26467634)
2015
4
Mixed subtype of congenital mesoblastic nephroma with poor evolution: a case report and literature review. (26811558)
2015
5
Congenital mesoblastic nephroma: A rare cause of recurrent hematuria beyond infancy. (23960358)
2013
6
Pathology in practice. Congenital mesoblastic nephroma. (21961632)
2011
7
Congenital mesoblastic nephroma. (20096866)
2010
8
Imaging of congenital mesoblastic nephroma with pathological correlation. (19629463)
2009
9
Pamidronate therapy for hypercalcemia and congenital mesoblastic nephroma: a case report. (20062638)
2009
10
Congenital mesoblastic nephroma rich from mitosis after in vitro fertilization: a case report. (18485932)
2008
11
Congenital mesoblastic nephroma presenting with neonatal hypertension. (15858607)
2005
12
Prenatal diagnosis of congenital mesoblastic nephroma in mid-second trimester by sonography and magnetic resonance imaging. (14634980)
2003
13
Use of sarcoma-based chemotherapy in a case of congenital mesoblastic nephroma with liver metastases. (12809924)
2003
14
Multicystic congenital mesoblastic nephroma. (11927972)
2002
15
Complete response of recurrent cellular congenital mesoblastic nephroma to chemotherapy. (12218597)
2002
16
Congenital mesoblastic nephroma (CMN) with an unusual immunohistochemical feature. (10371751)
1999
17
Congenital mesoblastic nephroma. (9361489)
1997
18
Congenital mesoblastic nephroma in a child with the Beckwith-Wiedemann syndrome. (9302166)
1997
19
A novel reciprocal translocation (14;15)(q11;q24) in a congenital mesoblastic nephroma. (8630977)
1996
20
Ultrastructure of cellular congenital mesoblastic nephroma. (8883325)
1996
21
The presence of hydrops fetalis in a fetus with congenital mesoblastic nephroma. (8734816)
1996
22
Congenital mesoblastic nephroma associated with focal and segmental sclerosis. (8587629)
1995
23
Congenital mesoblastic nephroma: an immunohistochemical and lectin study. (8387953)
1993
24
Nucleolar organizer regions in congenital mesoblastic nephroma. (1333074)
1992
25
Preoperative chemotherapy of cellular congenital mesoblastic nephroma in a 5-month-old infant. (1281666)
1992
26
Cytologic characteristics of congenital mesoblastic nephroma in fine-needle aspiration cytology: a case report. (1322264)
1992
27
Congenital mesoblastic nephroma, hemorrhagic shock, and disseminated intravascular coagulation in a newborn infant. (1851423)
1991
28
Pediatric case of the day. Congenital mesoblastic nephroma. (1653445)
1991
29
Congenital mesoblastic nephroma, nephrocalcinosis, and hypertrophic pyloric stenosis. (1656148)
1991
30
Hydrops fetalis and congenital mesoblastic nephroma. (1661640)
1991
31
Congenital mesoblastic nephroma occurring in a solitary kidney. (2157574)
1990
32
Congenital mesoblastic nephroma, renin production, and hypertension. (2544716)
1989
33
Classical and cellular (atypical) congenital mesoblastic nephroma: a clinicopathologic, ultrastructural, immunohistochemical, and flow cytometric study. (2544507)
1989
34
Two chromosomally different cell populations in a partly cellular congenital mesoblastic nephroma. (3030229)
1987
35
An abdominal mass: the congenital mesoblastic nephroma (CMN). The pathologic basis of its management. (3033249)
1986
36
Congenital mesoblastic nephroma of infancy. (3035027)
1986
37
Congenital mesoblastic nephroma with hypercalcemia. Pathogenetic role of prostaglandins. (3017143)
1986
38
Atypical mesoblastic nephroma. Pathologic characterization of a potentially aggressive variant of conventional congenital mesoblastic nephroma. (3004371)
1986
39
Cellular congenital mesoblastic nephroma in a newborn. (6097889)
1984
40
Congenital mesoblastic nephroma: relationship to other renal tumors of infancy. (6270389)
1981
41
Congenital mesoblastic nephroma. (6273522)
1981
42
Congenital mesoblastic nephroma: comparative histological study of three cases at different ages. (6285569)
1981
43
Tc-99m glucoheptonate renal imaging: congenital mesoblastic nephroma. (6249898)
1980
44
Congenital mesoblastic nephroma presenting with primary reninism. (221639)
1979
45
Congenital mesoblastic nephroma. (189563)
1976
46
Congenital mesoblastic nephroma of infancy. (189732)
1976
47
The management of benign renal tumors of infancy. Case report of a congenital mesoblastic nephroma (leiomyomatous hamartoma). (168170)
1975
48
Congenital mesoblastic nephroma of infancy. (164787)
1975
49
Letter: Congenital mesoblastic nephroma. (4370147)
1974
50
Congenital mesoblastic nephroma (leiomyomatous hamartoma): first adult case. (4355052)
1973

Variations for Congenital Mesoblastic Nephroma

About this section

Expression for genes affiliated with Congenital Mesoblastic Nephroma

About this section
Search GEO for disease gene expression data for Congenital Mesoblastic Nephroma.

Pathways for genes affiliated with Congenital Mesoblastic Nephroma

About this section

GO Terms for genes affiliated with Congenital Mesoblastic Nephroma

About this section

Cellular components related to Congenital Mesoblastic Nephroma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1nucleolusGO:00057308.8CTCF, ETV6, SMARCB1, WT1

Biological processes related to Congenital Mesoblastic Nephroma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1response to radiationGO:00093149.7IGF2, KIT
2regulation of gene expression by genetic imprintingGO:00063499.3CTCF, IGF2
3positive regulation of gene expressionGO:00106289.1CTCF, KIT, NTRK3

Sources for Congenital Mesoblastic Nephroma

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet